NuWays Reaffirms Buy Rating and NanoRepro Targets
NuWays maintained its €4.40 price target and confirmed NanoRepro's previously stated sales targets: approximately €18 million for fiscal 2026, €28 million for 2028 and €40 million for 2030. The report says initial distribution synergies are beginning to materialize.